MedReps.com (@MedRepscom) header
MedReps.com (@MedRepscom) profile picture

We are the medical sales industry's largest job board for #meddevice, #pharmaceutical, and #biotech #sales jobs.

Des Moines, IA
Joined September 2009
Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)Photo by MedReps.com (@MedRepscom)
Exploring medical sales opportunities in Florida? Start with these three employers with current openings on MedReps. hubs.ly/Q04FKr8V0
10
What makes Abbott's new UltiSynq defibrillation lead different from other cardiac pacing options? Abbott received FDA approval and a CE Mark for UltiSynq, a lead that combines conduction system pacing and defibrillation therapy in one device. For medical device sales professionals working in cardiac rhythm management, understanding the technology and clinical evidence is important when discussing new options with electrophysiologists. A few details worth knowing: ➡️ Dual-purpose technology: UltiSynq combines defibrillation therapy with left bundle branch area pacing. ➡️ Successful placement: The ASCEND CSP IDE trial reported a 98.5% successful placement rate across 205 implant attempts. ➡️ Pacing results: 86% of successfully implanted patients achieved true or likely left bundle branch pacing. ➡️ Early safety data: The three-month major complication-free rate was 97.5%. ➡️ Customer conversations: Representatives should understand patient selection, compatible ICD and CRT-D systems, and how the lead's combined capabilities differ from other options. For electrophysiology sales teams, product knowledge goes beyond explaining a device's features. It also means understanding the clinical evidence and where the technology may fit into physicians' treatment decisions. Read the full article: hubs.ly/Q04FkFC20
29
What happens when an orthopedic company decides its sales model needs an overhaul? Zimmer Biomet says commercial execution is behind much of its U.S. knee business underperformance. Its sales force restructuring offers insight into changing roles, hiring priorities, and the growing focus on specialized orthopedic coverage. 📌 Sales force changes: New incentives, leadership changes, and a shift toward direct employment. 📌 Dedicated coverage: More than 75% of U.S. representatives are now fully dedicated. 📌 Hiring priorities: Opportunities across sports medicine, extremities, robotics, and foot and ankle. 📌 Project Optima: Zimmer Biomet's eight-quarter plan to transform its U.S. sales organization. The Takeaway: Changes in sales structure can affect territory responsibilities, compensation, and opportunities across orthopedic medical device sales. Read the full article to understand what Zimmer Biomet's restructuring could mean for medical sales professionals. 🔗 hubs.ly/Q04FxGY80
40
In this week’s Hot Jobs roundup, we’re highlighting field reimbursement and market access roles across physician-office support, patient access, oncology analytics, and medical device reimbursement strategy. hubs.ly/Q04Ftdmq0
31
What happens after an implant is used in surgery, and how does the hospital pay for it? For medical device reps who support surgical cases, the bill-only process involves more than documenting which products the surgeon used. The hospital also needs accurate purchasing records before the supplier's invoice can be processed. Understanding Bill Sheets and Bill-Only POs can help reps recognize where documentation errors happen and why details matter. A few factors to consider: ➡️ Bill sheets record product usage: The rep documents the products used during the case, while hospital staff also capture usage information. ➡️ Bill-only POs document the purchase: The hospital uses the case information to create a purchase order for the products it needs to pay for. ➡️ Details need to match: Product numbers, quantities, and lot or serial information can affect whether purchasing records align. ➡️ Discrepancies can delay payment: Differences between the hospital's PO and the supplier's invoice may require manual review and reconciliation. ➡️ The process varies: Hospitals may use different systems and documentation requirements, so reps need to understand the procedures at their accounts. Accurate case documentation supports the administrative side of surgical device sales. Knowing how the process works can also help reps respond when a PO or invoice needs clarification. Read the full article: hubs.ly/Q04FkFy-0
1
66
Which healthcare developments could shape your next conversation with a physician or hospital customer? This week's roundup covers major moves across medical devices, pharmaceuticals, and biotech. From new FDA approvals to commercial expansion and clinical trial results, these developments offer useful context for reps following their markets and product categories. A few stories to watch: ➡️ Abbott's UltiSynq approval: A new defibrillation lead combines conduction system pacing and defibrillation, creating another product discussion for electrophysiology sales teams. ➡️ Francis Medical's financing: Johnson & Johnson-backed funding will support Vanquish commercial expansion, market access, and physician training in urology. ➡️ Novocure's FDA setback: The Not Approvable Letter for Optune Mya highlights the importance of understanding clinical endpoints and indication-specific regulatory status. ➡️ Bayer and EMD Serono approvals: Sunharbo and Pimjetmi bring new treatment options into stroke prevention and rare tumor care, with distinct patient populations and clinical considerations. ➡️ Beam Therapeutics' risto-cel results: Positive pivotal trial findings move the investigational sickle cell gene therapy closer to a potential regulatory submission. The roundup also covers NRx Pharmaceuticals' ketamine sales launch and Teva's plans to grow its innovative medicines portfolio. For medical sales professionals, following these developments helps connect product news with physician needs, market changes, and potential commercial opportunities. Read the full roundup: hubs.ly/Q04FkCR60
1
73
Considering rare disease or specialty pharma sales? Explore the daily responsibilities, specialist relationships, access challenges, and experience employers look for. hubs.ly/Q04DNC020
15
Device interview coming up? Prepare for the product presentation: know your audience, explain the evidence, and handle questions without guessing. Get practical tips and a presentation template. hubs.ly/Q04DNtZY0
22
Medtronic’s SPYRAL AFFIRM study adds real-world renal denervation data. Understand the study limits and labeling update: the device indication remains unchanged. hubs.ly/Q04DNwVb0
71
Exploring dental sales? Start with these three employers with relevant openings on their careers sites. hubs.ly/Q04F3hzM0
52
Philips launches HyperVue Integrated in U.S. cath labs. For cardiovascular reps, installation requirements, imaging capabilities, and clinical workflow shape the conversation. hubs.ly/Q04DNtZp0
40
Running a nursing in-service? Start with a clear training need, coordinate across shifts, and keep demonstrations practical. Our guide helps device reps plan sessions nurses can attend. hubs.ly/Q04DNfv00
23
In this week’s Hot Jobs roundup, we’re highlighting clinical specialist roles across TEG, joint replacement, interventional technologies, and regional clinical coverage. hubs.ly/Q04DT8f40
1
61
Edwards’ PROGRESS trial adds evidence on earlier TAVR. What do the results mean for structural heart sales? TAVR for moderate aortic stenosis remains investigational in the U.S. hubs.ly/Q04DNqx80
67
This week in medical sales: Edwards’ TAVR trial results, Medtronic’s renal denervation data, and Philips’ new cath lab system. Catch up on the evidence, regulatory context, and account conversations. hubs.ly/Q04DNFYF0
32
What should orthopedic sales reps know about Stryker’s acquisition of ZuriMED? Stryker has added the FiberLocker System to its Sports Medicine portfolio, bringing another rotator cuff augmentation technology into its shoulder care offering. For reps working with orthopedic surgeons, the key questions are how the technology works, what the clinical evidence shows, and how Stryker plans to integrate it into its existing portfolio. A few factors to consider: ➡️ Product knowledge: FiberLocker uses a polyester-fiber implant and surgical micro-stapling device to reinforce rotator cuff repairs. ➡️ Clinical evidence: Human studies began in 2025, but current research does not establish improved long-term outcomes. ➡️ Surgeon education: Training and familiarity will be important considerations as the technology is incorporated into shoulder care. ➡️ Portfolio integration: Watch how Stryker positions FiberLocker alongside its existing Sports Medicine and shoulder repair offerings. ➡️ Clinical messaging: Be prepared to explain the intended biomechanical benefit without overstating what the evidence demonstrates. For medical sales professionals, understanding a new product’s design, evidence, and place in the portfolio is an important part of supporting informed conversations with surgeons. Read the full article: hubs.ly/Q04DGrD80
65
Does your medical device sales quota reflect the opportunity in your territory? Your target may depend on more than last year’s sales. Product utilization, competitive conversions, hospital purchasing timelines, and capital budgets can all affect how much business you can realistically close. A few factors to consider: ➡️ Review the assumptions: Find out how historical performance and projected growth influenced your quota. ➡️ Look at territory potential: Consider eligible procedure volume, current product utilization, and realistic account opportunities. ➡️ Account for the sales cycle: Clinical interest doesn’t guarantee hospital approval, funding, or a purchase within the quota period. ➡️ Document what has changed: Record lost accounts, territory changes, delayed approvals, and operational barriers. ➡️ Ask specific questions: Clarify how your target was calculated, what support is available, and whether a formal quota review is possible. Medical device sales quotas are easier to evaluate when you understand the numbers behind them. That context can help you discuss expectations with your manager and assess the territory and compensation plan before accepting a new role. Read the full article: [LINK] hubs.ly/Q04DvG0l0
44
Every Thursday, MedReps looks at who’s hiring in medical sales and highlights one role worth watching. Job of the Week: Pharmaceutical Field Sales Representative - Canton, OH Annual Base Salary: $80K–$95K Industry: Biotechnology Function: Sales hubs.ly/Q04Dqr2w0 Interested in more roles like this? Check out MedReps for more medical sales roles and companies hiring now.
39
A surgical tray can arrive at the hospital and still not be ready for the case. Understanding the sterile processing department (SPD) helps medical device reps supporting reusable surgical instruments plan ahead, work with the right hospital contacts, and avoid preventable case-day complications. 📌 SPD workflow: Understand how instruments move from cleaning and inspection to sterilization and storage. 📌 Manufacturer instructions: Know where to find the current IFU and approved product documentation. 📌 Case readiness: Confirm loaner tray configurations, delivery requirements, and preparation timelines in advance. 📌 Team coordination: Understand how SPD, OR, and supply chain priorities intersect. The Takeaway: Strong surgical account management means understanding the operational steps that help get reusable instruments ready for use and knowing when to escalate questions to qualified personnel. Read the full article to learn how to work more effectively with SPD teams and support smoother surgical case planning. hubs.ly/Q04DjDB80
33
Exploring cardiovascular and structural heart sales? Start with these three employers with relevant openings on their careers sites. hubs.ly/Q04DjC7T0
38